Suppr超能文献

[运动负荷试验评估遗传性心律失常患者左心交感神经去神经术的治疗效果]

[Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test].

作者信息

Yang J, Li K, Chen D H, Yang F, Li J F, Xu B H, Liu Y W, She F, He R, Liu F, Cui Y C, Guo J H, Zhang P

机构信息

Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.

Department of thoracic surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Aug 24;49(8):796-801. doi: 10.3760/cma.j.cn112148-20200920-00747.

Abstract

To evaluate the efficiency of left cardiac sympathetic denervation (LCSD) in inherited arrhythmia patients with adrenergic activity-induced malignant ventricular arrhythmia, and observe exercise-stress test features before and after LCSD. This retrospective observational study included catecholaminergic polymorphic ventricular tachycardia(CPVT) and long QT syndromes(LQTS) patients who underwent video-assisted LCSD at Beijing Tsinghua Changgung Hospital and Peking University People's Hospital from September 2006 to May 2020. The indications for LCSD surgery were intolerant or refractory to beta-blocker medication. Clinical and exercise-stress tests data of included patients were collected before and 1 month after LCSD. Heart rate, exercise tolerance, atrial and ventricular arrhythmia, QTc interval and predictors for sudden cardiac death were analyzed. Patents were regularly followed up at 1, 3, 6, and 12 months after LCSD and then once every year thereafter. Cardiac events and medication adjustment records were collected. Five patients (2 CPVT, 1 LQT1, and 2 LQT2)were included in the study. All patients experienced syncope as first symptom at the median age of 12(10, 16)years, and underwent LCSD at the median age of 21(16, 26)years, Baseline heart rate was similar before and after LCSD ((65.6±6.5) beats/min vs. (68.0±11.1) beats/min, =0.57); while maximum workload tended to be lower after LCSD ((12.1±2.8) metabolic equivalents (METS) before surgery vs. (10.5±2.4) METS after surgery, =0.07). Incidence of atrial and ventricular arrhythmia were significantly reduced post LCSD, and the ventricular arrhythmia score was decreased after LCSD in CPVT patients (4 points before LCSD vs. 3 points after LCSD in case 1;5 points before LCSD vs. 3 points after LCSD in case 2). QTc interval was shortened significantly in three LQTs patients (QTc interval at baseline heart rate: (546.6±72.3) ms before surgery vs. (493±61.1) ms after LCSD, =0.047; QTc interval at maximal exercise heart rate: (516.3±73.7) ms before surgery vs. (486.7±64.2)ms after LCSD, =0.035). Additionally, sudden cardiac death risk indicator ΔHRR1 (heart rate decreasing value within the first 1 min during recovery phase) decreased from (51.5±21.1) beats/min before surgery to (32.0±13.9) beats/min after surgery (=0.035). During a median follow-up of 1(1, 4) year, all five patients were on low dosage of propranolol (37.0±21.7) mg/d. Cardiac events free survival was achieved in four out of 5 patients (80%) after sympathectomy, while 1 case suffered from sudden cardiac death after emotional stress. LCSD surgery can be safely and effectively performed in most hereditary arrhythmia patients with adrenergic activity-induced life-threatening cardiac events. Exercise stress test results show that LCSD could reduce malignant arrhythmias and improve sudden cardiac death risk indicators without decreasing heart rate.

摘要

为评估左心交感神经去神经术(LCSD)对因肾上腺素能活性诱导的恶性室性心律失常的遗传性心律失常患者的疗效,并观察LCSD前后运动应激试验的特征。这项回顾性观察性研究纳入了2006年9月至2020年5月在北京清华长庚医院和北京大学人民医院接受电视辅助LCSD的儿茶酚胺能多形性室性心动过速(CPVT)和长QT综合征(LQTS)患者。LCSD手术的指征是对β受体阻滞剂药物不耐受或难治。收集纳入患者在LCSD前和术后1个月的临床和运动应激试验数据。分析心率、运动耐量、房性和室性心律失常、QTc间期以及心脏性猝死的预测因素。在LCSD后1、3、6和12个月对患者进行定期随访,此后每年随访一次。收集心脏事件和药物调整记录。该研究纳入了5例患者(2例CPVT、1例LQT1和2例LQT2)。所有患者均以晕厥为首发症状,中位年龄为12(10,16)岁,并在中位年龄21(16,26)岁时接受了LCSD。LCSD前后的基线心率相似((65.6±6.5)次/分钟对(68.0±11.1)次/分钟,P = 0.57);而LCSD后最大工作量往往较低(术前(12.1±2.8)代谢当量(METS)对术后(10.5±2.4)METS,P = 0.07)。LCSD后房性和室性心律失常的发生率显著降低,CPVT患者LCSD后室性心律失常评分降低(病例1:LCSD前4分对LCSD后3分;病例2:LCSD前5分对LCSD后3分)。3例LQTS患者的QTc间期显著缩短(基础心率时的QTc间期:术前(546.6±72.3)毫秒对LCSD后(493±61.1)毫秒,P = 0.047;最大运动心率时的QTc间期:术前(516.3±73.7)毫秒对LCSD后(486.7±64.2)毫秒,P = 0.035)。此外,心脏性猝死风险指标ΔHRR1(恢复阶段第1分钟内心率下降值)从术前的(51.5±21.1)次/分钟降至术后的(32.0±13.9)次/分钟(P = 0.035)。在中位随访1(1,4)年期间,所有5例患者均服用低剂量普萘洛尔(37.0±21.7)mg/d。交感神经切除术后,5例患者中有4例(80%)实现了无心脏事件生存,而1例在情绪应激后发生心脏性猝死。LCSD手术可以在大多数因肾上腺素能活性诱导危及生命的心脏事件的遗传性心律失常患者中安全有效地进行。运动应激试验结果表明,LCSD可以减少恶性心律失常并改善心脏性猝死风险指标,而不会降低心率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验